Skip to main content
OpenTrials
Completed

NCT Number: NCT05823558

Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients

In osteoporosis, sarcopenia is a common condition. Sarcopenic measurements can be made by evaluating muscle thickness in different regions. We aim to evaluate lumbar muscle losses in patients with osteoporosis in the lumbar region and to examine whether these muscle losses are correlated with the level of osteoporosis. The patients will be divided into 3 groups as healthy, osteopenic and osteoporotic according to DEXA measurements. Demographic values, comorbidities, osteoporosis drugs used, fracture histories, L1-4, L2-4, femoral neck and total BMD and t values of the patients, psoas and multifidus muscle measurements will be made at L2-L3 level in Lumbar MR imaging. Lumbar MR muscle measurements will be made by 1 physician blind to the DEXA values of the patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Etfal Training and Research Hospital

Istanbul, 34100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 50-90 years old
  • 2. Recent MRI of the lumbar region with DEXA evaluation

Exclusion criteria

  • Have had previous lumbar surgery
  • Any previous lumbar injection
  • Stage 3-4 Lumbar Listesis
  • Presence of Lumbar Discopathy accompanied by neurological deficit

Treatment and study plan

Lomber Muscle Thickness Measurement

Diagnostic Test

Muscle thickness measurements will be made on the imaging of those who have lumbar MR imaging.

Primary outcomes

  1. Lomber Muscle Measurement

    Time frame: Day 1

    Psoas and multifidus muscle measurements will be made at L2-L3 level in Lumbar MR imaging.

Sponsors and collaborators

Lead sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 21, 2023
Registry last updated
Nov 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.